Latest developments

April 2015: First product receives approval
Syntropharma first transdermal project receives regulatory approval in Argentina.

December 2013: Syntropharma sign US agreement Syntropharma signs US marketing and distribution agreement with a major pharmaceutical player for generic transdermal product.

April 2013: Early access deal
Syntropharma signs EU agreement with Early Access Specialists Mytomorrows.

August 2012: Latin America, EU deal
Syntropharma concludes marketing and distribution agreement with Spanish based pharmaceutical business Ferrer for Latin American, Spain and Portugal.

New projects
Syntropharma is actively seeking partners to help bring their transdermal products to market.

Please contact: mailto:andrew.gardiner@syntropharma.com for more information.